These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21249144)
1. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. Wu CL; Kandarian SC; Jackman RW PLoS One; 2011 Jan; 6(1):e16171. PubMed ID: 21249144 [TBL] [Abstract][Full Text] [Related]
2. The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy. Jackman RW; Wu CL; Kandarian SC PLoS One; 2012; 7(12):e51478. PubMed ID: 23251550 [TBL] [Abstract][Full Text] [Related]
3. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. Hunter RB; Kandarian SC J Clin Invest; 2004 Nov; 114(10):1504-11. PubMed ID: 15546001 [TBL] [Abstract][Full Text] [Related]
4. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. Hunter RB; Stevenson E; Koncarevic A; Mitchell-Felton H; Essig DA; Kandarian SC FASEB J; 2002 Apr; 16(6):529-38. PubMed ID: 11919155 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50. Collins PE; Kiely PA; Carmody RJ J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141 [TBL] [Abstract][Full Text] [Related]
6. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide. Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067 [TBL] [Abstract][Full Text] [Related]
7. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs. Kohda A; Yamazaki S; Sumimoto H J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104 [TBL] [Abstract][Full Text] [Related]
8. Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Judge AR; Koncarevic A; Hunter RB; Liou HC; Jackman RW; Kandarian SC Am J Physiol Cell Physiol; 2007 Jan; 292(1):C372-82. PubMed ID: 16928772 [TBL] [Abstract][Full Text] [Related]
9. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352 [TBL] [Abstract][Full Text] [Related]
10. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction. Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505 [TBL] [Abstract][Full Text] [Related]
11. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart. Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423 [TBL] [Abstract][Full Text] [Related]
12. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. Thornburg NJ; Raab-Traub N J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446 [TBL] [Abstract][Full Text] [Related]
13. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Bourteele S; Oesterle K; Weinzierl AO; Paxian S; Riemann M; Schmid RM; Planz O Cell Microbiol; 2007 Sep; 9(9):2202-17. PubMed ID: 17573907 [TBL] [Abstract][Full Text] [Related]
14. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212 [TBL] [Abstract][Full Text] [Related]
15. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. Dai R; Phillips RA; Ahmed SA J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044 [TBL] [Abstract][Full Text] [Related]
16. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Mishra A; Bharti AC; Varghese P; Saluja D; Das BC Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793 [TBL] [Abstract][Full Text] [Related]
17. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. Wessells J; Baer M; Young HA; Claudio E; Brown K; Siebenlist U; Johnson PF J Biol Chem; 2004 Nov; 279(48):49995-50003. PubMed ID: 15465827 [TBL] [Abstract][Full Text] [Related]
18. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis. Reißig S; Tang Y; Nikolaev A; Gerlach K; Wolf C; Davari K; Gallus C; Masri J; Mufazalov IA; Neurath MF; Wunderlich FT; Schattenberg JM; Galle PR; Weigmann B; Waisman A; Glasmacher E; Hövelmeyer N Nat Commun; 2017 Apr; 8():15069. PubMed ID: 28452361 [TBL] [Abstract][Full Text] [Related]
20. The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. Elsharkawy AM; Oakley F; Lin F; Packham G; Mann DA; Mann J J Hepatol; 2010 Sep; 53(3):519-27. PubMed ID: 20579762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]